SAS | The Power to Know
cq5dam.thumbnail.319.319
White Paper

Enhancing Success Rates with Adaptive Clinical Trials

About this paper

Sponsors and clinical research organizations (CROs) are being very cautious in their utilization of adaptive clinical trial designs. And well they should be. While under the right circumstances, clinical trials can enhance the ethical treatment of patients, enable better decisions faster and help minimize the cost of clinical development, it is important to keep in mind that adaptive trials will not always be appropriate. This paper from Elsevier Business Intelligence discusses how adaptive clinical trials can provide a better way to explore and demonstrate the efficacy and safety of investigational products, while also emphasizing the point that a trial that forgoes validity for novelty is not a good trial.

Sobre o SAS

SAS é o líder de mercado em Analytics. Por meio de soluções analíticas inovadoras, voltadas para a inteligência do negócio e gerenciamento de dados, a companhia ajuda seus clientes em mais de 75.000 localidades a tomarem decisões de forma rápida e assertiva. Desde 1976, o SAS fornece aos clientes ao redor do mundo THE POWER TO KNOW® (O Poder do Conhecimento).

Já tem um Perfil SAS? Realize o preenchimento automático deste formulário. Entrar

*
*
*
*
 
*
*
 
 

Back to Top